Chia TAI Tianqing

JUN 10, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Fosaprepitant (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for fosaprepitant labeling; this is a regulatory action, not a clinical evidence record, and does not report trial outcomes or efficacy data.